◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Anlon Healthcare Limited (AHCL) Financial History

Name: Anlon Healthcare Limited (AHCL) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Anlon Healthcare Limited (AHCL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Rajkot, India with about 119 employees. Its market capitalization is roughly ₹12 billion. In the fiscal year ended 2026-03-31, AHCL reported ₹1.7B in revenue and ₹285M in net income.

Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates.

Interactive charts & full statements →

AHCL Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹1.7B	₹1.2B	₹666M	₹1.1B	—
Gross Profit	₹644M	₹448M	₹301M	₹245M	—
Operating Income (EBIT)	₹463M	₹306M	₹138M	₹111M	—
Net Income	₹285M	₹205M	₹97M	₹58M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AHCL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹876M	₹509M	₹356M	₹522M	₹333M	—
Gross Profit	₹215M	₹230M	₹155M	₹192M	₹91M	—
Operating Income (EBIT)	₹145M	₹150M	₹120M	₹133M	₹58M	—
Net Income	₹67M	₹105M	₹52M	₹93M	₹36M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AHCL Free Cash Flow History

AHCL Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹3.7B	₹1.8B	₹1.3B	₹1.1B	—
Total Liabilities	₹1.2B	₹1.0B	₹1.1B	₹1.0B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AHCL viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

AMRUTANJAN · Amrutanjan Health Care Limited — ₹14 billion
FERMENTA · Fermenta Biotech Limited — ₹14 billion
4574 · Taiko Pharmaceutical Co.,Ltd. — JPY 13 billion
IPN · Ipsen S.A. — €13 billion
LINCOLN · Lincoln Pharmaceuticals Limited — ₹12 billion
2627 · Ab&B Bio-Tech CO., LTD. JS — HK$12 billion
THEMISMED · Themis Medicare Limited — ₹12 billion
SIGACHI · Sigachi Industries Limited — ₹11 billion

← AHC All “A” companies AHCO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.